98 studies found for:
"Acromegaly"
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Unknown † |
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
|
||||
2 | Unknown † |
Lanreotide Levels in Acromegaly
|
||||
3 | Recruiting |
The Treatment and Natural History of Acromegaly
|
||||
4 | Completed |
Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
|
||||
5 | Unknown † |
Ultrasound Guided Sandostatin LAR Injection in Acromegaly
|
||||
6 | Completed |
Surgical Versus Medical Treatment of Acromegaly
|
||||
7 | Not yet recruiting |
Epidemiology of Acromegaly
|
||||
8 | Completed |
Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
|
||||
9 | Completed |
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
|
||||
10 | Active, not recruiting |
An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
|
||||
11 | Recruiting |
Efficacy and Safety of Octreolin for Acromegaly
|
||||
12 | Active, not recruiting |
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
|
||||
13 | Terminated |
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
|
||||
14 | Recruiting |
Study of Heart Effects When Growth Hormone (GH) is Used for Growth Hormone Deficiency (GHD) Following Cure of Acromegaly
|
||||
15 | Completed |
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
|
||||
16 | Not yet recruiting |
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
|
||||
17 | Completed |
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
|
||||
18 | Active, not recruiting |
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
|
||||
19 | Completed |
Acute Application of Pegvisomant and Octreotide in Acromegaly
|
||||
20 | Recruiting |
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
|
† Indicates status has not been verified in more than two years